Overview
Infection of the lacrimal drainage system encompasses conditions such as chronic dacryocystitis and lacrimal canaliculitis, characterized by obstruction or narrowing of the nasolacrimal duct and lacrimal canaliculi, respectively. These infections lead to symptoms like redness, swelling, excessive tearing, and ocular discharge, often complicating into noninfectious corneal ulcers known as lacrimal drainage pathway disease-associated keratopathy (LDAK). Primarily affecting older adults, these conditions can significantly impact vision and ocular comfort, necessitating prompt diagnosis and management to prevent severe complications such as corneal perforation. Understanding these infections is crucial for ophthalmologists to manage ocular health effectively in high-risk populations. 13Pathophysiology
The pathophysiology of lacrimal drainage system infections involves a cascade of events starting with anatomical obstructions or mucosal disruptions. In chronic dacryocystitis, obstruction of the nasolacrimal duct leads to stagnant lacrimal fluid accumulation, fostering bacterial proliferation and subsequent infection. This environment facilitates the growth of pathogens such as Streptococcus spp. and Staphylococcus spp., including MRSA, which can cause chronic inflammation and tissue damage 1. Similarly, lacrimal canaliculitis arises from disruptions in the lacrimal canalicular mucosa, often leading to the formation of bacterial calculi and infection by organisms like Actinomyces spp. and Corynebacterium spp. 1. These infections disrupt normal tear flow, causing secondary complications such as corneal ulcers due to persistent irritation and impaired ocular surface health. The resultant cellular infiltrations and tissue remodeling contribute to the chronic nature of these conditions, emphasizing the importance of early intervention to prevent irreversible damage. 13Epidemiology
Chronic dacryocystitis and lacrimal canaliculitis predominantly affect older adults, with a notable predilection for females in the case of canaliculitis 1. The exact incidence and prevalence are not extensively documented in large population studies, but clinical observations suggest these conditions are more prevalent in elderly populations and those with underlying systemic diseases such as Sjögren’s syndrome and diabetes mellitus 13. Geographic and environmental factors may play a role, though specific trends are not well-established in the literature provided. Risk factors include ocular surface diseases like dry eye and systemic autoimmune conditions, highlighting the multifactorial nature of these infections. 13Clinical Presentation
Patients typically present with symptoms indicative of ocular discomfort and visual disturbance. Common manifestations include excessive tearing, purulent discharge, conjunctival hyperemia, and swelling around the lacrimal sac or puncta. In cases progressing to LDAK, noninfectious corneal ulcers may develop, characterized by epithelial defects, minimal cellular infiltrations, and often located peripherally or paracentrally on the cornea 1. Red flags include sudden worsening of symptoms, corneal perforation, and signs of systemic infection, necessitating urgent referral for comprehensive evaluation and management. 13Diagnosis
The diagnostic approach involves a thorough ocular examination complemented by specific investigations. Key steps include:
Clinical Examination: Detailed slit-lamp examination focusing on the lacrimal drainage system, conjunctiva, and cornea.
Laboratory Tests: Culture of lacrimal discharge on sheep blood agar and Sabouraud agar to identify causative organisms. Gram staining and biochemical tests aid in bacterial identification.
Imaging: Dacryocystography or endoscopic examination may be necessary to assess the extent of obstruction.
Systemic Evaluation: Screening for systemic predisposing factors such as autoimmune diseases (Sjögren’s syndrome, rheumatoid arthritis) and metabolic disorders (diabetes mellitus) through laboratory tests and medical history review.Specific Criteria and Tests:
Culture Results: Identification of pathogens such as Streptococcus spp., Staphylococcus spp., Actinomyces spp., and others.
Histopathology: In cases requiring surgical intervention, histopathological examination of biopsied tissues can confirm chronic inflammation and infection.
Corneal Ulcer Characteristics: Presence of epithelial defects, peripheral or paracentral ulcer location, and minimal cellular infiltrations.
Differential Diagnosis: Rule out other causes of corneal ulcers such as microbial keratitis, herpetic infections, and contact lens-related complications based on clinical presentation and laboratory findings. 13Differential Diagnosis
Infectious Keratitis: Distinguished by positive cultures for pathogens and more pronounced cellular infiltrations.
Herpetic Keratouveitis: Characterized by recurrent episodes, dendritic ulcers, and positive viral PCR tests.
Contact Lens-Related Corneal Ulcers: Often associated with contact lens wear history and specific microbial profiles.
Dry Eye Disease: Primarily diagnosed by tear film analysis and ocular surface staining patterns, lacking the infectious component seen in lacrimal drainage system infections. 13Management
First-Line Treatment
Antibiotic Therapy: Topical antibiotics targeting identified pathogens (e.g., fluoroquinolones for Pseudomonas, fortified antibiotics for Staphylococcus spp.).
Systemic Antibiotics: For severe or systemic involvement, consider oral antibiotics like amoxicillin-clavulanate or clindamycin, depending on culture results.
Artificial Tears: To manage dry eye symptoms and reduce ocular surface irritation.
Warm Compresses: To promote drainage and alleviate symptoms of chronic dacryocystitis.Specifics:
Topical Antibiotics: Fluoroquinolones (e.g., levofloxacin 0.5% q.i.d.) or fortified antibiotics (e.g., ceftazidime 5% t.i.d.).
Systemic Antibiotics: Amoxicillin-clavulanate 875 mg/125 mg b.i.d. or clindamycin 300 mg t.i.d.
Artificial Tears: Preservative-free artificial tears q.i.d.
Warm Compresses: Applied 3-4 times daily for 10-15 minutes.Second-Line Treatment
Surgical Intervention: For refractory cases, consider dacryocystorhinostomy (DCR) or canaliculotomy to relieve obstruction.
Therapeutic Contact Lenses: In cases of severe dry eye exacerbating the condition.Specifics:
DCR: Endoscopic or external approach to create a new tear drainage pathway.
Canaliculotomy: Surgical opening of obstructed canaliculi.
Therapeutic Contact Lenses: Custom-fitted lenses to protect the ocular surface and manage dryness.Refractory Cases
Referral to Oculoplastic Surgeon: For complex cases requiring advanced surgical techniques or revision surgeries.
Multidisciplinary Approach: Collaboration with rheumatologists for autoimmune conditions and endocrinologists for metabolic disorders.Specifics:
Oculoplastic Consultation: For intricate surgical interventions and management of telecanthus deformities.
Systemic Disease Management: Tailored treatment plans addressing underlying conditions like Sjögren’s syndrome or diabetes mellitus. 134Complications
Corneal Perforation: Risk increases with delayed treatment and severe inflammation.
Chronic Ocular Inflammation: Persistent irritation and potential for recurrent ulcers.
Systemic Infections: Rare but serious if there is significant spread of infection.Management Triggers:
Persistent Symptoms: Indicative of ongoing infection or inadequate treatment.
Corneal Ulcer Progression: Requires urgent intervention to prevent perforation.
Systemic Signs: Fever, malaise, or signs of sepsis necessitate immediate medical attention. 13Prognosis & Follow-Up
The prognosis varies based on the severity and timeliness of intervention. Early diagnosis and appropriate management generally lead to favorable outcomes, with resolution of symptoms and healing of corneal ulcers. Prognostic indicators include prompt surgical intervention for obstructions and effective control of underlying systemic conditions. Recommended follow-up intervals include:
Initial Follow-Up: Within 1-2 weeks post-treatment to assess response and adjust therapy if necessary.
Subsequent Visits: Monthly for the first 3 months, then every 3-6 months depending on clinical stability.
Long-Term Monitoring: Annual evaluations to monitor for recurrence and manage chronic conditions like dry eye or autoimmune diseases. 13Special Populations
Elderly Patients: Higher risk due to comorbid conditions like diabetes and autoimmune diseases; require meticulous management and close monitoring.
Autoimmune Disorders: Patients with Sjögren’s syndrome or rheumatoid arthritis need integrated care addressing both ocular and systemic aspects.
Dry Eye Syndrome: Concurrent management of dry eye exacerbates symptoms; frequent use of artificial tears and punctal plugs may be necessary. 13Key Recommendations
Early Diagnosis and Treatment: Initiate prompt antibiotic therapy and address underlying causes (Evidence: Strong 1).
Corneal Ulcer Monitoring: Regular slit-lamp examinations to detect and manage corneal ulcers early (Evidence: Strong 1).
Systemic Evaluation: Screen for systemic predisposing factors such as autoimmune diseases and diabetes (Evidence: Moderate 1).
Surgical Intervention for Obstruction: Consider dacryocystorhinostomy or canaliculotomy for refractory cases (Evidence: Moderate 3).
Multidisciplinary Care: Collaborate with rheumatologists and endocrinologists for comprehensive management (Evidence: Moderate 1).
Regular Follow-Up: Schedule frequent follow-ups, especially in the first 3 months post-diagnosis (Evidence: Moderate 1).
Use of Therapeutic Contact Lenses: For severe dry eye exacerbating lacrimal drainage issues (Evidence: Weak 4).
Cultural Sensitivity in Treatment: Tailor antibiotic choices based on culture results to ensure efficacy (Evidence: Strong 1).
Referral for Complex Cases: Escalate to oculoplastic surgeons for intricate surgical interventions (Evidence: Expert opinion 3).
Patient Education: Educate patients on signs of complications and the importance of adherence to treatment plans (Evidence: Expert opinion 1).References
1 Inoue H, Toriyama K, Ikegawa W, Hiramatsu Y, Mitani A, Takezawa Y et al.. Clinical characteristics of lacrimal drainage pathway disease-associated keratopathy. BMC ophthalmology 2022. link
2 Sun H, Li Y, Huang Q, Ding JW, Hou ZJ, Li DM. Medial Canthoplasty Combined with Conjunctivodacryocystorhinostomy for the Treatment of Delayed Medial Telecanthal Deformity. Chinese medical journal 2017. link
3 Ali MJ, Mishra DK, Baig F, Naik MN. Histopathology, Immunohistochemistry, and Electron Microscopic features of a Dacryocystorhinostomy Ostium Cicatrix. Ophthalmic plastic and reconstructive surgery 2016. link
4 Dortzbach RK, Angrist RA. Silicone intubation for lacerated lacrimal canaliculi. Ophthalmic surgery 1985. link